|
Quality Id |
Measure Name |
High Priority |
Measure Type |
Measure Description |
|
005 |
Heart
Failure (HF): Angiotensin-Converting Enzyme (ACE)
Inhibitor or Angiotensin Receptor Blocker (ARB)
Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
No |
Process |
Percentage
of patients aged 18 years and older with a diagnosis of heart failure (HF)
with a current or prior left ventricular ejection fraction (LVEF) < 40%
who were prescribed ACE inhibitor or ARB therapy either within a 12 month
period when seen in the outpatient setting OR at each hospital discharge |
|
008 |
Heart
Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction
(LVSD) |
No |
Process |
Percentage
of patients aged 18 years and older with a diagnosis of heart failure (HF)
with a current or prior left ventricular ejection fraction (LVEF) < 40%
who were prescribed beta-blocker therapy either within a 12-month period when
seen in the outpatient setting OR at each hospital discharge |
|
047 |
Care
Plan |
Yes |
Process |
Percentage
of patients aged 65 years and older who have an advance care plan or
surrogate decision maker documented in the medical record that an advance
care plan was discussed but the patient did not wish or was not able to name
a surrogate decision maker or provide an advance care plan |
|
076 |
Prevention
of Central Venous Catheter (CVC) - Related Bloodstream Infections |
Yes |
Process |
Percentage
of patients, regardless of age, who undergo central venous catheter (CVC)
insertion for whom CVC was inserted with all elements of maximal sterile
barrier technique, hand hygiene, skin preparation and, if ultrasound is used,
sterile ultrasound techniques followed |
|
130 |
Documentation
of Current Medications in the Medical Record |
Yes |
Process |
Percentage
of visits for patients aged 18 years and older for which the eligible
professional or eligible clinician attests to documenting a list of current
medications using all immediate resources available on the date of the
encounter. This list must include ALL known prescriptions, over-the-counters,
herbals, and vitamin/mineral/dietary (nutritional) supplements AND must
contain the medications’ name, dosage, frequency and route of administration |
|
407 |
Appropriate
Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia |
No |
Process |
Percentage
of patients with sepsis due to MSSA bacteremia who
received beta-lactam antibiotic (e.g. nafcillin, oxacillin or cefazolin) as definitive therapy |